Back to Journals » Drug Design, Development and Therapy » Volume 9

Designing biologic selectivity for inflammatory bowel disease – role of vedolizumab

Total article views   HTML views PDF downloads Totals
10,737 Dovepress* 9,086+ 2,025 11,111
PubMed Central* 1,651 530 2,181
Totals 10,737 2,555 13,292
*Since 17 December 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar